Melbourne’s PolyActiva Completes Recruitment in Key Phase I Glaucoma Implant Safety Study.
Six-month Treatment Period Demonstrated.
Company receives additional AU$10m to continue clinical development of biodegradable eye implant: https://t.co/jcDNrwGxL0 via @BusinessWire
Excellent speakers at the BioMelbourne Connecting Women lunch. So many inspiring women and men uniting to become each others best allies in the workplace #biomelbwomen @biomelb